Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Raul Gonzalez

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
capital markets, corporate, corporate and capital markets
Office
Bay Area
Active in the record
2020 to 2024

Deal experience

Deal types
Capital Markets & IPODebt Capital MarketsM&A
Sectors
Consumer & RetailHealthcare & Life SciencesTechnology
Jurisdictions
United States

Deals

10 announced deals in the record
Latham & Watkins Advises BridgeBio Pharma in US$1.25 Billion Cross-Border Funding 22 Jan 2024
Debt Capital Markets Healthcare & Life Sciences Latham & Watkins LLP USD 1.25bn corporate and capital markets
Latham & Watkins Advises e.l.f. Beauty in Its Acquisition of Naturium 30 Aug 2023
M&A Consumer & Retail Latham & Watkins LLP USD 355m securities
Latham & Watkins Advises on 4D Molecular Therapeutics’ Pricing of Upsized Public Offering of Common Stock 6 May 2023
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 120m corporate
Latham & Watkins Advises on Reneo Pharmaceuticals’ Public Offering of Common Stock and Concurrent Private Placement 5 May 2023
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 55m capital markets Bay Area
Latham & Watkins Advises on Vaxcyte US$500 Million Public Offering 20 Apr 2023
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 500m capital markets
Latham & Watkins Advises Planet Labs in De-SPAC Merger with dMY Technology Group IV 7 Jul 2021
Capital Markets & IPO Technology Latham & Watkins LLP USD 2.80bn capital markets
Latham & Watkins Advises the Underwriters in Lyell Immunopharma’s US$425 Million IPO 17 Jun 2021
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 425m capital markets Bay Area
Latham & Watkins Advises the Underwriters in Talis Biomedical’s Initial Public Offering 12 Feb 2021
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 221m corporate
Latham Advises the Underwriters in Silverback Therapeutics’ Initial Public Offering 4 Dec 2020
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 242m life sciences capital markets Bay Area
Latham & Watkins Advises Tizona Therapeutics in Acquisition by Gilead Sciences 21 Jul 2020
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 300m corporate Bay Area
Deal alerts PRO

Get an email when Raul Gonzalez is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Pro

Analytics for Raul Gonzalez

The paid plans add analytics for this lawyer, and for every firm and lawyer in the database:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
SEE PLANS SIGN IN
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction